[1]韦金秀,刘礼剑,黎丽群,等.基于网络药理学和分子对接探讨归芍生腺汤治疗慢性萎缩性胃炎的作用机制[J].西部中医药,2025,38(05):94-99.[doi:10.12174/j.issn.2096-9600.2025.05.18]
　WEI Jinxiu,LIU Lijian,LI Liqun,et al.Mechanism of Treatment of Chronic Atrophic Gastritis with Guishao Shengxian Tang Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2025,38(05):94-99.[doi:10.12174/j.issn.2096-9600.2025.05.18]
点击复制

基于网络药理学和分子对接探讨归芍生腺汤治疗慢性萎缩性胃炎的作用机制()
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
38
期数:
2025年05期
页码:
94-99
栏目:
二次研究
出版日期:
2025-05-15

文章信息/Info

Title:
Mechanism of Treatment of Chronic Atrophic Gastritis with Guishao Shengxian Tang Based on Network Pharmacology and Molecular Docking
作者:
韦金秀1, 刘礼剑1, 黎丽群1, 杨成宁1, 钟焕英2
1.广西中医药大学第一附属医院，广西 南宁 530023
2.广西中医药大学，广西 南宁 530200
Author(s):
WEI Jinxiu1, LIU Lijian1, LI Liqun1, YANG Chengning1, ZHONG Huanying2
1.The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning 530023, China
2.Guangxi University of Chinese Medicine, Nanning 530200, China
关键词:
慢性萎缩性胃炎; 归芍生腺汤; 网络药理学; 分子对接
Keywords:
chronic atrophic gastritis; network pharmacology; molecular docking
分类号:
R256.3
DOI:
10.12174/j.issn.2096-9600.2025.05.18
文献标志码:
A
摘要:
目的采用网络药理学方法分析归芍生腺汤治疗慢性萎缩性胃炎（chronic atrophic gastritis，CAG）的作用机制。 方法从中药系统药理学数据库与分析平台（traditional Chinese medicine systems pharmacology database and analysis platform，TCMSP）、中药分子机制的生物信息学分析工具（abioinformatics analysis tool for molecular mechanism of traditional Chinese medicine，BATMAN-TCM）数据库检索归芍生腺汤各味药的主要化学成分，并从TCMSP、传统中药集成数据库（traditional chinese medicine integrated database，TCMID）、SwissTargetPrediction等数据库获取主要化学成分的靶点信息。采用Cytoscape构建网络模型并进行网络分析，用STRING和RStudio软件进行靶点功能富集分析。通过AutoTools软件进行分子对接验证。 结果归芍生腺汤共12味中药，包含145个活性化合物、340个化合物预测靶点、105个化合物和疾病相关共同靶点，其中归芍生腺汤治疗CAG的关键基因有白细胞介素6（interleukin 6，IL-6）、肿瘤坏死因子（tumor necrosis factor，TNF）、信号转导及转录激活蛋白3（signal transducer and activator of transcription 3，STAT3）、表皮生长因子受体（epidermal growth factor receptor，EGFR）、缺氧可诱导因子1α（（hypoxia-inducible factor 1-alpha，HIF-1α）和蛋白激酶B1（protein kinase B 1，AKT1）。富集分析提示归芍生腺汤是通过多通路、多靶点治疗CAG，其中包括PI3K-AKT、HIF-1、JAK-STAT等信号通路。分子对接结果表明归芍生腺汤活性化合物与IL-6、TNF、STAT3、EGFR、HIF-1α和AKT1关键靶点具有较高结合能力。 结论归芍生腺汤治疗CAG具有多成分、多靶点和多通路的药效特点，为其治疗提供新思路。
Abstract:
ObjectiveTo analyze the mechanism of Guishao Shengxian Tang in the treatment of chronic atrophic gastritis (CAG) based on network pharmacology. MethodsThe main chemical ingredients of Guishao Shengxian Tang were searched from TCMSP and BATMAN - TCM, the information of the targets of the main chemical ingredients were obtained from TCMSP, TCMID, and SwissTargetPrediction. Cytoscape was used to construct the network models and perform network analysis, STRING and R Studio were applied to conduct enrichment analysis of targets. Molecular docking validation was performed by AutoTools software. ResultsThere were 12 herbs contained in Guishao Shengxian Tang, containing 145 active compounds, 340 predicted targets of the compounds, 105 shared targets between compounds and diseases, among them, the key genes of the treatment of CAG by Guishao Shengxian Tang were IL-6, TNF, STAT3, EGFR, HIF-1α and Akt. Enrichment analysis suggested that the decoction is a multi-pathway, multi-targeted treatment for CAG, among them, the pathways contain PI3K-AKT signaling pathway, HIF-1 signaling pathway and JAK-STAT signaling pathway. The results of molecular docking indicated that active compounds of the decoction have high binding capacity to the key targets of IL-6, TNF, STAT3, EGFR, HIF-1α and AKT. ConclusionThe decoction could treat CAG through multi-ingredient, multi-target and multi-pathway, which could provide new ideas for the treatment of CAG.

相似文献/References:

[1]舒劲.制萎扶胃丸防治慢性萎缩性胃炎作用机制[J].西部中医药,2014,27(07):131.
　SHU Jin.The Mechanism of ZhiWei FuWei Pill in the Prevention and Treatment for Chronic Atrophic Gastritis[J].Western Journal of Traditional Chinese Medicine,2014,27(05):131.
[2]段永强,指导：王道坤.王道坤教授治疗慢性萎缩性胃炎的临床思路与经验[J].西部中医药,2014,27(11):46.
[3]马艳君,林寿宁,唐少波.慢性萎缩性胃炎中医辨证分型与胃黏膜组织p53蛋白表达的相关性研究*[J].西部中医药,2015,28(01):60.
[4]杨舒淳,吴芳,李龑,等.李玉贤主任医师应用辛开苦降法治疗慢性萎缩性胃炎经验[J].西部中医药,2016,29(07):45.
　YANG Shuchun,WU FANG,LI Yan,et al.Chief Physician Li Yuxian′s Experience of Applying Acrid Opening and Bitter Downbearing Method to Chronic Atrophic Gastritis[J].Western Journal of Traditional Chinese Medicine,2016,29(05):45.
[5]张嘉玲,丘富程,刘芬芳,等.穴位埋线治疗萎缩性胃炎的文献计量学分析[J].西部中医药,2018,31(08):58.
　ZHANG Jialing,QIU Fucheng,LIU Fenfang,et al.Bibliometrics Analysis of Catgut Implantation at Acupoint in the Treatment for Atrophic Gastritis[J].Western Journal of Traditional Chinese Medicine,2018,31(05):58.
[6]寇媛,赵倩,段盛蕾,等.养胃清热化瘀法治疗慢性萎缩性胃炎及癌前病变的临床研究[J].西部中医药,2019,32(01):63.
　KOU Yuan,ZHAO Qian,DUAN Shenglei,et al.Clinical Study on the Method of Stomach-nourishing Heat-clearing Stasis-Removing in Treating Chronic Atrophic Gastritis and Precancerous Lesion[J].Western Journal of Traditional Chinese Medicine,2019,32(05):63.
[7]曾寒泊,麻春杰△,魏玉霞,等.胃和冲剂Ⅱ号对慢性萎缩性胃炎寒热错杂证患者胃黏膜PTEN和ERK-2蛋白表达的影响[J].西部中医药,2019,32(07):16.
　ZENG Hanbo,MA Chunjie,WEI Yuxia,et al.Effects of WeiHe Granules No.Ⅱ on the Expressions of Gastric Mucosa PTEN and ERK-2 Protein of the Patients with CAG of Intermingled Heat and Cold Pattern[J].Western Journal of Traditional Chinese Medicine,2019,32(05):16.
[8]陈璐,汶明琦,王捷虹,等.调胃饮对慢性萎缩性胃炎大鼠血清胃泌素和前列腺素E2的调控作用[J].西部中医药,2019,32(07):24.
　CHEN Lu,WEN Mingqi,WANG Jiehong,et al.Regulatory Effects of TiaoWei Drink on Gastrin and Prostaglandin E2 of CAG Rats[J].Western Journal of Traditional Chinese Medicine,2019,32(05):24.
[9]马立华,蔡柏.柴芍六君加味方抑制慢性萎缩性胃炎患者胃黏膜腺体萎缩及机制研究[J].西部中医药,2019,32(07):80.
　MA Lihua,CAI Bo.Study on the Effects and Mechanism of Modified Chaishao Liujun Prescription in Inhibiting Gastric Mucosa Gland Atrophy of CAG Patients[J].Western Journal of Traditional Chinese Medicine,2019,32(05):80.
[10]王强,张晓鹏,周语平,等.香砂六君子汤对萎缩性胃炎大鼠IL-6、IL-17及ERK1/2基因蛋白表达的影响[J].西部中医药,2020,33(07):16.[doi:10.12174/j.issn.1004-6852.2020.07.04]
　WANG Qiang,ZHANG Xiaopeng,ZHOU Yuping,et al.Influence of Xiangsha Liujunzi Decoction on the Expressions of IL-6, IL-17 and ERK1/2 Gene Protein in CAG Rats[J].Western Journal of Traditional Chinese Medicine,2020,33(05):16.[doi:10.12174/j.issn.1004-6852.2020.07.04]

备注/Memo

备注/Memo:
韦金秀（1985—），女，硕士学位，副主任医师。研究方向：中医药防治胃肠病。国家自然科学基金（82160877）；广西自然科学基金（2018GXNSFBA281130，2021JJB140037）。
更新日期/Last Update: 2025-05-15